- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
IDSI gets NASDAQ stock listing
Laser mammography developer Imaging Diagnostic Systems announcedthis month that its stock will be listed on theNASDAQ stock exchange.The Plantation, FL, company, which is developing a mammographyscanner that uses laser light rather than x-rays, said the
Laser mammography developer Imaging Diagnostic Systems announcedthis month that its stock will be listed on theNASDAQ stock exchange.The Plantation, FL, company, which is developing a mammographyscanner that uses laser light rather than x-rays, said the moveshould help analysts and investors follow its stock more closely.IDSI's stock had been trading on the OTC Bulletin Board.
In other IDSI news, the company announced that it will conductphase I clinical trials for its CT Laser Mammography device atColumbia JFK Medical Center in Atlantis, FL. IDSI will submitan amendment to its existing investigational device exemption(IDE) to incorporate Columbia JFK as a clinical site. Once theamendment is accepted, IDSI will be able to use the hospital'sextensive database of patients with breast abnormalities.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
